F
Felix M. Mottaghy
Researcher at RWTH Aachen University
Publications - 458
Citations - 22729
Felix M. Mottaghy is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Medicine & Positron emission tomography. The author has an hindex of 63, co-authored 415 publications receiving 18456 citations. Previous affiliations of Felix M. Mottaghy include Forschungszentrum Jülich & University of Würzburg.
Papers
More filters
Journal ArticleDOI
Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin,Ralph T.H. Leijenaar,Timo M. Deist,Jurgen Peerlings,Evelyn E.C. de Jong,Janita E. van Timmeren,Sebastian Sanduleanu,Ruben T. H. M. Larue,Aniek J.G. Even,Arthur Jochems,Yvonka van Wijk,Henry C. Woodruff,Johan van Soest,Tim Lustberg,Erik Roelofs,Wouter van Elmpt,Andre Dekker,Felix M. Mottaghy,Felix M. Mottaghy,Joachim E. Wildberger,Sean Walsh +20 more
TL;DR: Radiomics, the high-throughput mining of quantitative image features from standard-of-care medical imaging that enables data to be extracted and applied within clinical-decision support systems to improve diagnostic, prognostic, and predictive accuracy, is gaining importance in cancer research as mentioned in this paper.
Journal ArticleDOI
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
Malik E. Juweid,Sigrid Stroobants,Otto S. Hoekstra,Felix M. Mottaghy,Markus Dietlein,Ali Guermazi,Gregory A. Wiseman,Lale Kostakoglu,Klemens Scheidhauer,Andreas K. Buck,Ralph Naumann,Karoline Spaepen,Rodney J. Hicks,Wolfgang A. Weber,Sven N. Reske,Markus Schwaiger,Lawrence H. Schwartz,Josée M. Zijlstra,Barry A. Siegel,Bruce D. Cheson +19 more
TL;DR: The International Harmonization Project (IHP) developed guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment in patients with lymphoma both in clinical practice and in clinical trials as discussed by the authors.
Journal ArticleDOI
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard,Michael O'Doherty,Wolfgang A. Weber,Felix M. Mottaghy,Markus Nowak Lonsdale,Sigrid Stroobants,Wim J.G. Oyen,Joerg Kotzerke,Otto S. Hoekstra,Jan Pruim,Paul Marsden,Klaus Tatsch,Corneline J. Hoekstra,Eric P. Visser,Bertjan Arends,Fred J. Verzijlbergen,Josée M. Zijlstra,Emile F.I. Comans,Adriaan A. Lammertsma,Anne M. J. Paans,Antoon T. M. Willemsen,Thomas Beyer,Andreas Bockisch,Cornelia M. Schaefer-Prokop,Dominique Delbeke,Richard P. Baum,Arturo Chiti,Bernd J. Krause +27 more
TL;DR: This guideline will address general information about [18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out, interpret, and document quantitative FDG PET/CT examinations.
Journal ArticleDOI
Cold acclimation recruits human brown fat and increases nonshivering thermogenesis
Anouk A.J.J. van der Lans,Joris Hoeks,Boudewijn Brans,Guy H. E. J. Vijgen,Mariëlle G. W. Visser,Maarten J. Vosselman,Jan Hansen,Johanna A. Jörgensen,Jun Wu,Felix M. Mottaghy,Patrick Schrauwen,Wouter D. van Marken Lichtenbelt +11 more
TL;DR: It is shown that a 10-day cold acclimation protocol in humans increases BAT activity in parallel with an increase in nonshivering thermogenesis (NST) and may contribute to counteracting the current obesity epidemic.
Journal ArticleDOI
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.
Kambiz Rahbar,Hojjat Ahmadzadehfar,Clemens Kratochwil,Uwe Haberkorn,Michael Schäfers,Markus Essler,Richard P. Baum,Harshad R. Kulkarni,Matthias Schmidt,Alexander Drzezga,Peter Bartenstein,Andreas Pfestroff,Markus Luster,Ulf Lützen,Marlies Marx,Vikas Prasad,Winfried Brenner,Alexander Heinzel,Felix M. Mottaghy,Juri Ruf,Philipp T. Meyer,Martin Heuschkel,Maria Eveslage,Martin Bögemann,Wolfgang P. Fendler,Bernd J. Krause +25 more
TL;DR: The present retrospective multicenter study of 177Lu-PSMA-617 RLT demonstrates favorable safety and high efficacy exceeding those of other third-line systemic therapies in mCRPC patients.